
MYND Life Sciences announces funding for Psilocybin research on Neuroinflammation
R&D project on psilocybin’s benefits in treating diseases of the brain VANCOUVER, BC, Nov. 30, 2021 /CNW/ – MYND Life Sciences...
MYND Life Sciences announces funding for Psilocybin research on Neuroinflammation
MYND Life Sciences announces funding for Psilocybin research on Neuroinflammation
MYND Diagnostics Commences Clinical Research on Multiple Sclerosis Biomarker Test